Roberto Tinoco

2.6k total citations
26 papers, 1.7k citations indexed

About

Roberto Tinoco is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Roberto Tinoco has authored 26 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 11 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Roberto Tinoco's work include Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Roberto Tinoco is often cited by papers focused on Immune Cell Function and Interaction (11 papers), Immunotherapy and Immune Responses (10 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Roberto Tinoco collaborates with scholars based in United States, United Kingdom and Israel. Roberto Tinoco's co-authors include Linda M. Bradley, Anne S. Dejean, Diego H. Castrillón, Ronald A. DePinho, Daniel R. Beisner, Yann M. Kerdiles, Stephen Μ. Hedrick, Elina I. Zúñiga, Víctor Alcalde and Karsten Sauer and has published in prestigious journals such as The Lancet, Nature Communications and Immunity.

In The Last Decade

Roberto Tinoco

24 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberto Tinoco United States 16 920 601 477 132 120 26 1.7k
Sunil K. Raghav India 23 968 1.1× 912 1.5× 669 1.4× 114 0.9× 206 1.7× 71 2.2k
Sigurd Krieger Austria 19 454 0.5× 687 1.1× 523 1.1× 103 0.8× 195 1.6× 35 1.7k
Theresa H. Page United Kingdom 18 847 0.9× 449 0.7× 245 0.5× 98 0.7× 132 1.1× 26 1.4k
Runqing Lu United States 23 797 0.9× 759 1.3× 444 0.9× 85 0.6× 233 1.9× 36 2.0k
Mrinal K. Sarkar United States 25 894 1.0× 551 0.9× 235 0.5× 237 1.8× 224 1.9× 43 1.8k
Robert Plenge United States 11 471 0.5× 337 0.6× 306 0.6× 268 2.0× 93 0.8× 17 1.3k
Patrice Decker France 27 1.2k 1.3× 1.0k 1.7× 848 1.8× 406 3.1× 81 0.7× 48 2.5k
Jason E. Hawkes United States 20 1.4k 1.5× 546 0.9× 400 0.8× 196 1.5× 288 2.4× 55 2.4k
Anne Lafond-Walker United States 13 1.3k 1.4× 716 1.2× 711 1.5× 52 0.4× 100 0.8× 17 2.2k
Sheela Ramanathan Canada 30 1.1k 1.2× 526 0.9× 665 1.4× 70 0.5× 142 1.2× 99 2.3k

Countries citing papers authored by Roberto Tinoco

Since Specialization
Citations

This map shows the geographic impact of Roberto Tinoco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Tinoco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Tinoco more than expected).

Fields of papers citing papers by Roberto Tinoco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Tinoco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Tinoco. The network helps show where Roberto Tinoco may publish in the future.

Co-authorship network of co-authors of Roberto Tinoco

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Tinoco. A scholar is included among the top collaborators of Roberto Tinoco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Tinoco. Roberto Tinoco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Viramontes, Karla M., et al.. (2025). Contrasting roles of PSGL-1 and PD-1 in regulating T-cell exhaustion and function during chronic viral infection. Journal of Virology. 99(3). e0224224–e0224224.
2.
Sun, Peng, Christina N. Kraus, Wei Zhao, et al.. (2025). Spatial and Single-Cell Transcriptomics Reveal Keratinocytes as Key Players in Vulvar Lichen Sclerosus Pathogenesis. Journal of Investigative Dermatology. 146(3). 678–698.e5.
3.
Lewis, Sloan A., et al.. (2023). HMGB2 regulates the differentiation and stemness of exhausted CD8+ T cells during chronic viral infection and cancer. Nature Communications. 14(1). 5631–5631. 20 indexed citations
4.
Viramontes, Karla M., et al.. (2022). Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1–Resistant Melanoma. Cancer Immunology Research. 10(5). 612–625. 19 indexed citations
5.
Kumar, Priyanka, Jennifer B. Goldstein, Katrine Whiteson, et al.. (2022). The cure from within? a review of the microbiome and diet in melanoma. Cancer and Metastasis Reviews. 41(2). 261–280. 12 indexed citations
6.
Viramontes, Karla M., et al.. (2022). PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells. Frontiers in Immunology. 13. 869768–869768. 15 indexed citations
7.
Tinoco, Roberto, et al.. (2021). PSGL-1 Is a T Cell Intrinsic Inhibitor That Regulates Effector and Memory Differentiation and Responses During Viral Infection. Frontiers in Immunology. 12. 677824–677824. 12 indexed citations
8.
Viramontes, Karla M., et al.. (2021). PSGL-1 Immune Checkpoint Inhibition for CD4+ T Cell Cancer Immunotherapy. Frontiers in Immunology. 12. 636238–636238. 39 indexed citations
9.
Scortegagna, Marzia, Kathryn Hockemeyer, Igor Dolgalev, et al.. (2020). Siah2 control of T-regulatory cells limits anti-tumor immunity. Nature Communications. 11(1). 99–99. 17 indexed citations
10.
Li, Yan, Lisa Elmeń, Igor Šegota, et al.. (2020). Prebiotic-Induced Anti-tumor Immunity Attenuates Tumor Growth. Cell Reports. 30(6). 1753–1766.e6. 129 indexed citations
11.
Fujita, Yu, Roberto Tinoco, Yan Li, Daniela Senft, & Ze’ev A. Ronai. (2019). Ubiquitin Ligases in Cancer Immunotherapy – Balancing Antitumor and Autoimmunity. Trends in Molecular Medicine. 25(5). 428–443. 41 indexed citations
12.
Sakuma, Stephen, Marcela Raı́ces, Florent Carrette, et al.. (2018). Nuclear pore complex-mediated modulation of TCR signaling is required for naïve CD4+ T cell homeostasis. Nature Immunology. 19(6). 594–605. 30 indexed citations
13.
Fujita, Yu, Ali Khateb, Yan Li, et al.. (2018). Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis. Cell Reports. 24(12). 3296–3311.e6. 44 indexed citations
14.
Tinoco, Roberto, et al.. (2017). PSGL-1: A New Player in the Immune Checkpoint Landscape. Trends in Immunology. 38(5). 323–335. 100 indexed citations
15.
Tinoco, Roberto, Florent Carrette, Dennis C. Otero, et al.. (2016). PSGL-1 Is an Immune Checkpoint Regulator that Promotes T Cell Exhaustion. Immunity. 44(5). 1190–1203. 129 indexed citations
16.
Baaten, Bas, Roberto Tinoco, Alex T. Chen, & Linda M. Bradley. (2012). Regulation of Antigen-Experienced T Cells: Lessons from the Quintessential Memory Marker CD44. Frontiers in Immunology. 3. 23–23. 106 indexed citations
17.
Tinoco, Roberto, Víctor Alcalde, Yating Yang, Karsten Sauer, & Elina I. Zúñiga. (2009). Cell-Intrinsic Transforming Growth Factor-β Signaling Mediates Virus-Specific CD8+ T Cell Deletion and Viral Persistence In Vivo. Immunity. 31(1). 145–157. 214 indexed citations
18.
Kerdiles, Yann M., Daniel R. Beisner, Roberto Tinoco, et al.. (2009). Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nature Immunology. 10(2). 176–184. 409 indexed citations
19.
Nielsen, K., D. Gall, F.J. Martínez-Moreno, et al.. (2002). FIELD TRIAL OF THE BRUCELLOSIS FLUORESCENCE POLARIZATION ASSAY. Journal of Immunoassay and Immunochemistry. 23(3). 307–316. 12 indexed citations
20.
Blair, Ian A., Roberto Tinoco, Martin J. Brodie, et al.. (1985). Plasma Hydrazine Concentrations in Man after Isoniazid and Hydralazine Administration. Human Toxicology. 4(2). 195–202. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026